Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine

Iris Eke1, Adeola Y Makinde1, Molykutty J Aryankalayil1

  • 1Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Cancer Letters
|February 2, 2016
PubMed

Insights

Advanced molecular profiling, including genomics and epigenetics, helps understand cancer cell processes and targeted therapy resistance. These "omics-based" methods are crucial for optimizing radiation oncology treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer involves complex molecular processes requiring advanced analysis.
  • Understanding cell death and survival mechanisms is key for targeted therapeutics and overcoming tumor resistance.
  • Genomic and epigenetic analyses are clinically used, while other omics assays are developing.

Purpose of the Study:

  • To provide an overview of current molecular profiling methods in cancer research.
  • To discuss promising research strategies and challenges in molecular profiling.
  • To explore the emerging role of molecular profiling in radiation oncology.

Main Methods:

  • Review of existing and emerging omics-based assays (genomics, epigenetics, proteomics, metabolomics).
  • Analysis of technologies for molecular profiling in cancer.
  • Examination of clinical applications and research frontiers.

Main Results:

  • Molecular profiling technologies are advancing rapidly, offering deeper insights into cancer.
  • Genomic and epigenetic analyses are established, with proteomics and metabolomics showing great potential.
  • Challenges include data integration and standardization of omics assays.

Conclusions:

  • Molecular profiling is essential for understanding cancer and developing effective targeted therapies.
  • Emerging omics technologies hold significant promise for personalized radiation oncology.
  • Continued research and development are needed to overcome challenges and fully leverage molecular profiling.